Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.

Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases. — المؤلف: Uemura, Hirotsugu — International journal of clinical oncology 20190710

المؤلف
Uemura, Hirotsugu
النشر
International journal of clinical oncology 20190710
الوصف
557-566 p.
الموضوعات
Administration, Intravenous؛ Aged؛ Anemia؛ Bone Neoplasms؛ Follow-Up Studies؛ Hematologic Diseases؛ Humans؛ Male